Search
for
Sort by
Research 241–270 of 1000+
- Obesity and the skin
- LB1605 3D imaging of cleared ex vivo normal human skin, skin appendages and psoriasiform skin lesion using light-sheet microscopy
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- Montagna Symposium 2015: Harnessing Stem Cells to Reveal Novel Skin Biology and Disease Treatments
- The Use of Stem Cell Differentiation Stage Factors (SCDSFs) Taken from Zebrafish Embryos during Organogenesis and Their Role in Regulating the Gene Expression of Normal and Pathological (Stem) Cells
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- Obesity and the skin: Skin physiology and skin manifestations of obesity
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
- Extraskeletal actions of vitamin D
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Niosomes as Carrier in Dermal Drug Delivery
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Evolving approaches to profiling the microbiome in skin disease
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Metabolic Syndrome and Skin Disease: Potential Connection and Risk
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- The role of janus kinases in the treatment of autoimmune skin diseases
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation
- Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- N02. Hair and Nails